BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1020945)

  • 21. [Protein-nitrogen metabolism in the liver of rats intraperitoneally administered carminomycin].
    Vetoshkina TV; Gol'dberg ED; Sal'nik BIu; Bakhareva GI
    Antibiotiki; 1979 Feb; 24(2):127-33. PubMed ID: 434802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes.
    Working PK; Newman MS; Sullivan T; Yarrington J
    J Pharmacol Exp Ther; 1999 May; 289(2):1128-33. PubMed ID: 10215696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antitumor activity of carminomycin antibiotic used orally].
    Shorin VA; Bazhanov VS; Averbukh LA
    Antibiotiki; 1976 Nov; 21(11):1005-7. PubMed ID: 1037187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The structural bases of the cardiotoxic action of the anti-tumor antibiotic carminomycin].
    Ishchenko VE; Blagodarov VN; Kulik GI; Grigor'eva NN
    Lik Sprava; 1992; (11-12):119-22. PubMed ID: 1292207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The utility of changes in cardiac weight as an index of drug-induced cardiotoxicity.
    Lowe MC; Gram TE; Guarino AM
    J Environ Pathol Toxicol Oncol; 1985; 6(1):57-68. PubMed ID: 4067835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cross resistance in tumor cells and staphylococci with respect to anthracycline-group antineoplastic antibiotics].
    Shorin VA; Averbukh LA
    Antibiotiki; 1976 Oct; 21(10):914-9. PubMed ID: 999240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transgenic mice overexpressing metallothionein are not resistant to adriamycin cardiotoxicity.
    DiSilvestro RA; Liu J; Klaassen CD
    Res Commun Mol Pathol Pharmacol; 1996 Aug; 93(2):163-70. PubMed ID: 8884987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.
    Sun X; Zhou Z; Kang YJ
    Cancer Res; 2001 Apr; 61(8):3382-7. PubMed ID: 11309296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary echocardiographic and polygraphic evaluation of cardiac toxicity of 4'-epi-doxorubicin.
    Villani F; Comazzi R; Lacaita G; Genitoni V; Guindani A; Martini A
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):203-8. PubMed ID: 6574995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute ultrastructural effects of the antitumor antibiotic carminomycin on nucleoli of rat tissues.
    Merski JA; Daskal Y; Crooke ST; Busch H
    Cancer Res; 1979 Apr; 39(4):1239-44. PubMed ID: 421207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of methimazole treatment on doxorubicin-induced cardiotoxicity in mice.
    Osman AM; Nemnem MM; Abou-Bakr AA; Nassier OA; Khayyal MT
    Food Chem Toxicol; 2009 Oct; 47(10):2425-30. PubMed ID: 19577608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of doxorubicin and its analogue mitoxantrone on cardiac muscle and on serum lipids: an experimental study.
    Koutinos G; Stathopoulos GP; Dontas I; Perrea-Kotsarelis D; Couris E; Karayannacos PE; Deliconstantinos G
    Anticancer Res; 2002; 22(2A):815-20. PubMed ID: 12014656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Liver mono-oxygenases and the pharmacodynamics of carminomycin and rubomycin].
    Bogush TA; Sitdikova SM
    Antibiotiki; 1984 Jun; 29(6):446-50. PubMed ID: 6476808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Late effects of the hematotoxic action of antineoplastic antibiotics of the anthracycline group].
    Gol'dberg ED; Novitskiĭ VV; Fursov SE
    Antibiot Khimioter; 1988 Sep; 33(9):671-6. PubMed ID: 3218991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A study of the toxicity, pharmacokinetics and pharmacodynamics of the new antitumor antibiotic carminomycin].
    Goldberg LE; Filippos'iants ST; Kunrat IA; Stepanova ES; Shepelevtseva NG
    Antibiotiki; 1974 Jan; 19(1):57-62. PubMed ID: 4463841
    [No Abstract]   [Full Text] [Related]  

  • 36. Toxicity of 3'-deamino-3'-(3-cyano-4-morpholinyl) doxorubicin and doxorubicin in nude mice bearing human tumour xenografts.
    Ford CH; Richardson VJ; Pushpanathan C; Ali SK
    Anticancer Res; 1991; 11(5):1855-62. PubMed ID: 1768056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Synthesis, toxicity and antitumor action of carminomycin azine (carminazine)].
    Povarov LS; Gol'dberg LE; Bazhanov VS; Shepelevtseva NG; Vertogradova TP
    Antibiotiki; 1981 Aug; 26(8):620-3. PubMed ID: 6895293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of selenium, WR-2721, and their combination in the prevention of adriamycin-induced cardiotoxicity in rats.
    Dobrić S; Dragojević-Simić V; Bokonjić D; Milovanović S; Marincić D; Jović P
    J Environ Pathol Toxicol Oncol; 1998; 17(3-4):291-9. PubMed ID: 9726805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of carminomycin on the energy metabolism of the liver in rats].
    Bulanova LA; Gol'dberg ED; Sal'nik BIu; Chulalina NP
    Antibiotiki; 1979 Mar; 24(3):218-24. PubMed ID: 443783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The toxicological evaluation of carminomycin - an antineoplastic anthracycline antibiotic.
    Buroker RA; Johnson DF; Madissoo H
    Drug Chem Toxicol; 1981; 4(4):383-96. PubMed ID: 7344912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.